ArticleInternational journal of hematology-oncology and stem cell research2023

The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-Positive HER2-Negative Non-Metastatic Breast Cancer.

Ria Etikasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.